Click to enlarge

GUIDELINES Pocketcard™ is a tri-fold pocketcard containing society-endorsed, evidence-based treatment guidelines in a brief algorithmic format that is most preferred by practicing clinicians, quality managers, nurses, educators, and medical students.^{1, 2}

The Bone-Modifying Agents in Metastatic Breast Cancer GUIDELINES Pocketcard™ is endorsed by the American Society of Clinical Oncology (ASCO) and based on their latest guidelines. This practical quick-reference tool includes timing of therapy, a management algorithm, FDA-approved drug list, toxicities and safety concerns—all the essential components from ASCO's full-text guidelines—and is approved by the ASCO Practice Guidelines Committee. The Bone-Modifying Agents in Metastatic Breast Cancer GUIDELINES Pocketcard™ provides all that is needed to make accurate clinical decisions at the point of care including:

• Key Points
• Indications and Timing of Therapy
• Role of BMAs in the Presence of Extraskeletal Metastases
• Laboratory Monitoring
• Drug Toxicities and Risks
• Osteonecrosis of the Jaw
• Role of BMAs in Pain Control
• Management Algorithm
• Current Medication Tables with Brand and Generic Names

Applications: point-of-care, education, QI interventions, clinical trials, medical reference, clinical research.

¹2007 PDR Physician Survey
²VA-HHS national guidelines attribute preference survey